Airway diseases
Symposium
State of the art session: Airway disease
Clinical
Update on clinical studies
Aims : to highlight the latest developments in airway diseases; to provide new clinical evidence that can be used to help diagnose and treat patients with severe asthma and COPD; to analyse novel ways of defining the pathogenic mechanisms of disease and how this may lead to a new treatment approach for severe asthma and COPD; to describe the important role of comorbidities in patients with severe asthma and COPD as well as analysis of their effects on disease evolution; to discuss the early-life origin of airway diseases; to provide clear and practical take-home knowledge relating to the prevention, diagnosis, history and treatment of severe asthma and COPD.
Target audience :
Allergist, Clinical researcher, Paediatrician, Scientist (basic, translational), Trainee, Adult pulmonologist/Clinician
Methods :
Cell and molecular biology, Epidemiology, Pulmonary function testing
14:45
ERS/TSANZ statement on care of patients with airways disease during pregnancy
P. Middleton(Sydney (NSW), Australia)
COI
V. Backer(Copenhagen, Denmark)
COI
1
3232
15:15
Early-life origin of airway diseases
A. Agusti Garcia-Navarro(Barcelona, Spain)
COI
-
Description
2
3233
15:45
Comorbidities in severe asthma
F. Schleich(Liège, Belgium)
COI
-
Description
3
3234
16:15
Exacerbations of respiratory symptoms in COPD
L. Fabbri(Modena, Italy)
COI
-
Description
4
3235
16:45
What is the role of oral corticosteroids in the era of biologics in asthma?
I. Pavord(Oxford (Oxfordshire), United Kingdom)
COI
-
Description
5
3236
. . .